IL6 and graft versus host disease: Of note, the administration of HDL to mice undergoing allo-HCT significantly improved overall survival and reduced GvHD severity by lowering circulating endotoxin, well-known GvHD triggers and amplifiers from intestinal gram-negative bacteria, and systemic (serum IL-6) and local inflammation (Kupffer cell-derived IL-12) [34].